April 2, 2019
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 4546
Washington, D.C. 20549
Attn: Christine Westbrook
Re: | Cara Therapeutics, Inc. |
Registration Statement on Form S-3 |
File No. 333-230333 |
Acceleration | Request |
Requested Date: Thursday, April 4, 2019
Requested Time: 4:00 P.M. Eastern Daylight Time
Dear Ms. Westbrook:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the Registrant) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-230333) (the Registration Statement) to become effective on April 4, 2019, at 4:00 p.m. Eastern Daylight Time, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Darren DeStefano of Cooley LLP, counsel to the Registrant, at (703) 456-8034, or in his absence, Alison Haggerty at (212) 479-6596.
Very truly yours, | ||
Cara Therapeutics, Inc. | ||
By: | /s/ Scott Terrillion | |
Scott Terrillion | ||
General Counsel, Secretary and Chief | ||
Compliance Officer |
cc: | Derek Chalmers, Ph.D., D.Sc., Cara Therapeutics, Inc. |
Darren K. DeStefano, Cooley LLP |
Alison A. Haggerty, Cooley LLP |